{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:22:49Z","timestamp":1792300969067,"version":"4.4.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,20]]},"DOI":"10.4103\/0366-6999.181959","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T10:21:18Z","timestamp":1462530078000},"page":"1224-1228","source":"Crossref","is-referenced-by-count":11,"title":["Benefits of Fixed Dose Combination of Ramipril\/Amlodipine in Hypertensive Diabetic Patients"],"prefix":"10.1097","volume":"129","author":[{"given":"Gabor","family":"Simonyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ncpendmet0638","article-title":"Diabetes and hypertension","volume":"3","author":"Lago","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R3-14-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/sj.jhh.1002254","article-title":"Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade","volume":"21","author":"Weir","year":"2007","journal-title":"J Hum Hypertens"},{"key":"R9-14-20210129","first-page":"34","article-title":"Monitoring of the blood pressure lowering effectiveness of ramipril-amlodipine fix combination \u2013 A non-interventional trial (RAMONA study) (Hungarian)","volume":"17","author":"Tomcs\u00e1nyi","year":"2013","journal-title":"Hypertonia es Nephrologia"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.HYP.36.5.901","article-title":"Prognostic significance of blood pressure and heart rate variabilities: The Ohasama study","volume":"36","author":"Kikuya","year":"2000","journal-title":"Hypertension"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.clinthera.2008.09.008","article-title":"An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine\/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: The assessment of combination therapy of amlodipine\/ramipril (ATAR) study","volume":"30","author":"Miranda","year":"2008","journal-title":"Clin Ther"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: A meta-analysis","volume":"174","author":"Cheng","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R13-14-20210129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the anglo-scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): A multicentre randomised controlled trial","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.181959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:39:06Z","timestamp":1623958746000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201605200-00014"}},"subtitle":["A Subgroup Analysis of RAMONA Trial"],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.181959","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,20]]}}}